The Indian government reduced the ability of the country's drug-pricing regulator to set prices on some drugs after pharmaceutical companies complained.
from WSJ.com: US Business http://ift.tt/1uCzURa
via IFTTT
from WSJ.com: US Business http://ift.tt/1uCzURa
via IFTTT
No comments:
Post a Comment